SternbergZLeungCSternbergD. The prevalence of the classical and non-classical cardiovascular risk factors in multiple sclerosis patients. CNS Neurol Disord Drug Targets. 2013;12:104–111.
De KeyserJSteenCMostertJP. Hypoperfusion of the cerebral white matter in multiple sclerosis: possible mechanisms and pathophysiological significance. J Cereb Blood Flow Metab. 2008;28:1645–1651.
7.
IngleseMParkSJJohnsonG. Deep gray matter perfusion in multiple sclerosis: dynamic susceptibility contrast perfusion magnetic resonance imaging at 3 T. Arch Neurol. 2007;64:196–202.
8.
MezeiZOlahLKardosL. Cerebrovascular hemodynamic changes in multiple sclerosis patients during head-up tilt table test: effect of high-dose intravenous steroid treatment. J Neurol. 2013;260:2335–2342.
UrsinoMLodiCA. Interaction among autoregulation, CO2 reactivity, and intracranial pressure: a mathematical model. Am J Physiol. 1998;274:H1715–H1728.
11.
GisolfJvan LieshoutJJvan HeusdenK. Human cerebral venous outflow pathway depends on posture and central venous pressure. J Physiol. 2004;560:317–327.
12.
RossAJMedowMSRowePC. What is brain fog? An evaluation of the symptom in postural tachycardia syndrome. Clin Auton Res. 2013;23:305–311.
13.
Martinez-MartinezLAMoraTVargasA. Sympathetic nervous system dysfunction in fibromyalgia, chronic fatigue syndrome, irritable bowel syndrome, and interstitial cystitis: a review of case-control studies. J Clin Rheumatol. 2014;20:146–150.
14.
MallienJIsenmannSMrazekA. Sleep disturbances and autonomic dysfunction in patients with postural orthostatic tachycardia syndrome. Front Neurol. 2014;5:118.
15.
PeroutkaSJ. Migraine: a chronic sympathetic nervous system disorder. Headache. 2004;44:53–64.
ZivadinovRMarrKCutterG. Prevalence, sensitivity, and specificity of chronic cerebrospinal venous insufficiency in MS. Neurology. 2011;77:138–144.
18.
DolicKWeinstock-GuttmanBMarrK. Risk factors for chronic cerebrospinal venous insufficiency (CCSVI) in a large cohort of volunteers. PLoS One. 2011;6:e28062.
19.
LeeBBBaumgartnerIBerlienP. Diagnosis and treatment of venous malformations. Consensus document of the International Union of Phlebology (IUP): updated 2013. Int Angiol. 2015;34:97–149.
20.
PascoloLGianoncelliARizzardiC. Calcium micro-depositions in jugular truncular venous malformations revealed by synchrotron-based XRF imaging. Sci Rep. 2014;4:6540.
21.
ZamboniPTisatoVMenegattiE. Ultrastructure of internal jugular vein defective valves [published online June 27, 2014]. Phlebology. doi:10.1177/0268355514541980.
22.
CoenMMenegattiESalviF. Altered collagen expression in jugular veins in multiple sclerosis. Cardiovasc Pathol. 2013;22:33–38.
23.
RoijersRBDuttaRKCleutjensJP. Early calcifications in human coronary arteries as determined with a proton microprobe. Anal Chem. 2008;80:55–61.
24.
RoijersRBDebernardiNCleutjensJP. Microcalcifications in early intimal lesions of atherosclerotic human coronary arteries. Am J Pathol. 2011;178:2879–2887.
25.
BadimonLVilahurG. Thrombosis formation on atherosclerotic lesions and plaque rupture. J Intern Med. 2014;276:618–632.
26.
LaBoureneJIColesJGJohnsonDJ. Alterations in elastin and collagen related to the mechanism of progressive pulmonary venous obstruction in a piglet model. A hemodynamic, ultrastructural, and biochemical study. Circ Res. 1990;66:438–456.
27.
FittsMKPikeDBAndersonK. Hemodynamic shear stress and endothelial dysfunction in hemodialysis access. Open Urol Nephrol J. 2014;7(suppl 1 M5):33–44.
28.
Roy-ChaudhuryPKhanRCamposB. Pathogenetic role for early focal macrophage infiltration in a pig model of arteriovenous fistula (AVF) stenosis. J Vasc Access. 2014;15:25–28.
29.
Bayes-GenisACampbellJHCarlsonPJ. Macrophages, myofibroblasts and neointimal hyperplasia after coronary artery injury and repair. Atherosclerosis. 2002;163:89–98.
30.
SchubertACattaruzzaMHeckerM. Shear stress-dependent regulation of the human beta-tubulin folding cofactor d gene. Circ Res. 2000;87:1188–1194.
ChristiansenCF. Risk of vascular disease in patients with multiple sclerosis: a review. Neurol Res. 2012;34:746–753.
33.
VandenbergheNDebouverieMAnxionnatR. Cerebral venous thrombosis in four patients with multiple sclerosis. Eur J Neurol. 2003;10:63–66.
34.
SungEAmezcuaLCenS. Multiple sclerosis and stroke [abstract]. Neurology. 2014;82(10 Suppl):169.
35.
AllenNBLichtmanJHCohenHW. Vascular disease among hospitalized multiple sclerosis patients. Neuroepidemiology. 2008;30:234–238.
36.
TsengCHHuangWSLinCL. Increased risk of ischaemic stroke among patients with multiple sclerosis. Eur J Neurol. 2015;22:500–506.
37.
ZollerRPMarkALAbboudFM. The role of low pressure baroreceptors in reflex vasoconstrictor responses in man. J Clin Invest. 1972;51:2967–2972.
38.
SternbergZ. Promoting sympathovagal balance in multiple sclerosis; pharmacological, non-pharmacological, and surgical strategies. Autoimmun Rev. 2015May3. doi: 10.1016/j.autrev.2015.04.012. [Epub ahead of print]
39.
CuiJMcQuillanPMBlahaC. Limb venous distension evokes sympathetic activation via stimulation of the limb afferents in humans. Am J Physiol Heart Circ Physiol. 2012;303:H457–H463.
40.
MannMCExnerDVHemmelgarnBR. Vitamin D levels are associated with cardiac autonomic activity in healthy humans. Nutrients. 2013;5:2114–2127.
41.
VarbiroSSaraLAntalP. Lower-limb veins are thicker and vascular reactivity is decreased in a rat PCOS model: concomitant vitamin D3 treatment partially prevents these changes. Am J Physiol Heart Circ Physiol. 2014;307:H848–H857.
